| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.008 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.009 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.34 | 0.01 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |